High incidence of thoracic lesions with characteristic mutational signature in mouse strains commonly used in pre-clinical studies after treatment with a DNA-alkylating agent
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP515617
下载链接
链接失效反馈官方服务：
资源简介：
We have shown that GBM patient-derived mouse orthotopic xenografts (PDX) present variable sensitivity to TMZ treatment, depending on their DNA-repair capacity. Furthermore, we have observed a high incidence of symptomatic secondary thoracic lesions several weeks after TMZ treatment in the mouse PDX lines that are highly responsive to treatment.
创建时间：
2024-09-30
